Anzeige
Meldung des Tages: Spark Energy Minerals: warum diese Aktie jetzt besonders interessant ist!

Becton Dickinson News

Aktie
WKN:  857675 ISIN:  US0758871091 US-Symbol:  BDX Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
176,48 $
-0,18 $
-0,10%
149,33 € 27.02.26
Depot/Watchlist
Marktkapitalisierung *
47,80 Mrd. €
Streubesitz
5,15%
KGV
31,83
Dividende
2,93 EUR
Dividendenrendite
2,21%
Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500

Becton Dickinson News

25.02.26 - PR Newswire
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase PR Newswire
25.02.26 - PR Newswire
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap PR Newswire
23.02.26 - PR Newswire
BD to Present at Barclays 28th Annual Global Healthcare Conference
BD to Present at Barclays 28th Annual Global Healthcare Conference PR Newswire
23.02.26 - PR Newswire
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency PR Newswire
19.02.26 - PR Newswire
Lanesha Minnix Named General Counsel for BD
Lanesha Minnix Named General Counsel for BD PR Newswire
10.02.26 - PR Newswire
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR Newswire
09.02.26 - PR Newswire
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR Newswire
09.02.26 - PR Newswire
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation PR Newswire
09.02.26 - PR Newswire
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR Newswire
09.02.26 - PR Newswire
BD Reports First Quarter Fiscal 2026 Financial Results
BD Reports First Quarter Fiscal 2026 Financial Results PR Newswire
29.01.26 - PR Newswire
BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care
BD and Envetec Demonstrate Closed-​Loop Recycling Solution for Laboratory Plastics in Health Care PR Newswire
27.01.26 - PR Newswire
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 PR Newswire
27.01.26 - PR Newswire
BD to Announce Financial Results for its First Quarter of Fiscal 2026
BD to Announce Financial Results for its First Quarter of Fiscal 2026 PR Newswire
27.01.26 - PR Newswire
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business PR Newswire
27.01.26 - PR Newswire
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business PR Newswire
27.01.26 - PR Newswire
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business PR Newswire
23.01.26 - PR Newswire
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
BD Helps Scientists Advance Immunology and Cancer Research with AI-​Powered Insights and Automation PR Newswire
21.01.26 - PR Newswire
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market PR Newswire
15.01.26 - PR Newswire
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System PR Newswire
14.01.26 - PR Newswire
BD Names Shawn Bevec as Senior Vice President of Investor Relations
BD Names Shawn Bevec as Senior Vice President of Investor Relations PR Newswire

Newssuche

Videos

newspaper
25.02.26
So beeinflussen Margins DEIN Trading
Börsentäglich ab 18 Uhr Feierabend-​Trading Live. Teilnahme kostenlos mit diesem Link ... Mehr »